NO954609D0 - Niopecotiske syrederivater som antitrombiske forbindelser - Google Patents

Niopecotiske syrederivater som antitrombiske forbindelser

Info

Publication number
NO954609D0
NO954609D0 NO954609A NO954609A NO954609D0 NO 954609 D0 NO954609 D0 NO 954609D0 NO 954609 A NO954609 A NO 954609A NO 954609 A NO954609 A NO 954609A NO 954609 D0 NO954609 D0 NO 954609D0
Authority
NO
Norway
Prior art keywords
compounds
niopecotic
antithrombic
acid derivatives
telet
Prior art date
Application number
NO954609A
Other languages
English (en)
Other versions
NO954609L (no
NO304885B1 (no
Inventor
Mary Pat Beavers
Patricia Andrade-Gordon
William J Hoekstra
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NO954609D0 publication Critical patent/NO954609D0/no
Publication of NO954609L publication Critical patent/NO954609L/no
Publication of NO304885B1 publication Critical patent/NO304885B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO954609A 1994-03-16 1995-11-15 Nipectoin syrederivater som antitrombe forbindelser NO304885B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21377294A 1994-03-16 1994-03-16
US36489694A 1994-12-27 1994-12-27
PCT/US1995/003145 WO1995025091A2 (en) 1994-03-16 1995-03-14 Nipecotic acid derivatives as antithrombic compounds

Publications (3)

Publication Number Publication Date
NO954609D0 true NO954609D0 (no) 1995-11-15
NO954609L NO954609L (no) 1996-01-05
NO304885B1 NO304885B1 (no) 1999-03-01

Family

ID=26908383

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954609A NO304885B1 (no) 1994-03-16 1995-11-15 Nipectoin syrederivater som antitrombe forbindelser

Country Status (20)

Country Link
US (1) US5770575A (no)
EP (1) EP0746545B1 (no)
JP (1) JPH09510453A (no)
KR (1) KR100328287B1 (no)
CN (1) CN1083834C (no)
AT (1) ATE180470T1 (no)
AU (1) AU703397B2 (no)
CA (1) CA2163027A1 (no)
DE (1) DE69509875T2 (no)
DK (1) DK0746545T3 (no)
ES (1) ES2131313T3 (no)
FI (1) FI113763B (no)
GR (1) GR3030566T3 (no)
HU (1) HUT74871A (no)
MX (1) MX9504800A (no)
NO (1) NO304885B1 (no)
NZ (1) NZ283209A (no)
RU (1) RU2135470C1 (no)
TW (1) TW318179B (no)
WO (1) WO1995025091A2 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6380215B1 (en) * 1993-09-22 2002-04-30 Fujisawa Pharmaceutical Co., Ltd Beta-alanine derivative and a process for the preparation thereof
CA2215106A1 (en) * 1995-03-17 1996-09-26 Fujisawa Pharmaceutical Co., Ltd. N-acylpiperidinylcarbonylaminocarboxylic acids and their use as glycoprotein iib/iiia antagonists and fibrinogen-blood platelets binding inhibitors
WO1997033869A1 (en) * 1996-03-13 1997-09-18 Fujisawa Pharmaceutical Co., Ltd. N-[(r)-1-{3-(4-piperidyl)propionyl-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist
ATE421952T1 (de) * 1996-05-01 2009-02-15 Ortho Mcneil Pharm Inc Carboxamidderivate von pyrrolidin, piperidin und hexahydropiperizin für behandlung von thrombosen
EP1184374B1 (en) * 1996-05-01 2009-01-28 Ortho-McNeil Pharmaceutical, Inc. Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
DE19741235A1 (de) * 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
US6066651A (en) 1997-10-29 2000-05-23 Ortho-Mcneil Pharmaceutical, Inc. Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders
US6020347A (en) * 1997-11-18 2000-02-01 Merck & Co., Inc. 4-substituted-4-piperidine carboxamide derivatives
AU1415099A (en) * 1997-11-18 1999-06-07 Merck & Co., Inc. 4-substituted-4-piperidine carboxamide derivatives
UA67832C2 (uk) * 1999-03-22 2004-07-15 Орто-Макнейл Фармацевтикал, Інк. СПОСІБ ОТРИМАННЯ [S-(R<sup>*</sup>,S<sup>*</sup>)]-<font face="Symbol">b</font>-[[[1-[1-ОКСО-3-(4-ПІПЕРИДИНІЛ)ПРОПІЛ]-3-ПІПЕРИДИНІЛ]КАРБОНІЛ]АМІНО]-3-ПІРИДИНПРОПАНОВОЇ КИСЛОТИ ТА ЇЇ ПОХІДНИХ
AUPQ570100A0 (en) * 2000-02-17 2000-03-09 Fujisawa Pharmaceutical Co., Ltd. Beta-alanine derivatives and their use as receptor antagonists
WO2005079863A1 (ja) 2004-02-25 2005-09-01 Astellas Pharma Inc. 血栓造影剤
EP3184149A1 (en) * 2015-12-23 2017-06-28 Julius-Maximilians-Universität Würzburg Soluble glycoprotein v for treating thrombotic diseases
CN109734655B (zh) * 2019-03-11 2020-06-02 都创(上海)医药科技有限公司 一种fkbp配体的同型二聚体合成工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US5318899A (en) * 1989-06-16 1994-06-07 Cor Therapeutics, Inc. Platelet aggregation inhibitors
TW201303B (no) * 1990-07-05 1993-03-01 Hoffmann La Roche
MX9100517A (es) * 1990-08-06 1992-04-01 Smith Kline French Lab Compuestos
EP0617705B1 (en) * 1991-11-22 1997-09-24 Yeda Research And Development Company, Ltd. Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them
US5219867A (en) * 1991-12-16 1993-06-15 Research Corporation Technologies, Inc. Platelet aggregation inhibitory agents
US5358934A (en) * 1992-12-11 1994-10-25 The United States Of America As Represented By The Secretary Of Agriculture Materials and methods for control of pests
US5559209A (en) * 1993-02-18 1996-09-24 The General Hospital Corporation Regulator regions of G proteins

Also Published As

Publication number Publication date
FI955498A0 (fi) 1995-11-15
NZ283209A (en) 1998-04-27
AU703397B2 (en) 1999-03-25
AU2119195A (en) 1995-10-03
JPH09510453A (ja) 1997-10-21
FI955498A (fi) 1996-01-15
NO954609L (no) 1996-01-05
MX9504800A (es) 1997-05-31
FI113763B (fi) 2004-06-15
EP0746545A1 (en) 1996-12-11
CN1083834C (zh) 2002-05-01
WO1995025091A3 (en) 1995-10-12
DE69509875T2 (de) 1999-12-09
WO1995025091A2 (en) 1995-09-21
CA2163027A1 (en) 1995-09-21
NO304885B1 (no) 1999-03-01
DE69509875D1 (de) 1999-07-01
HU9503270D0 (en) 1996-05-28
EP0746545B1 (en) 1999-05-26
HUT74871A (en) 1997-02-28
GR3030566T3 (en) 1999-10-29
KR100328287B1 (ko) 2002-10-11
RU2135470C1 (ru) 1999-08-27
CN1128022A (zh) 1996-07-31
DK0746545T3 (da) 1999-11-08
TW318179B (en) 1997-10-21
ATE180470T1 (de) 1999-06-15
ES2131313T3 (es) 1999-07-16
US5770575A (en) 1998-06-23

Similar Documents

Publication Publication Date Title
NO971538L (no) Purin- og guaninforbindelser som inhibitorer for PNP
BR9900177A (pt) Inibidores de metaloprotease.
DK0560268T3 (da) Substituerede pipecolinsyrederivater som HIV-proteasehæmmere
NO954609L (no) Niopecotiske syrederivater som antitrombiske forbindelser
DK0594702T3 (da) Substituerede indoler som midler mod AIDS
NO963370L (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
EA200000204A1 (ru) Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов
NO972887D0 (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
NO20022977L (no) Substituerte homopiperidinylbenzimidazolanaloger som fundiske relaksanter
ES2168355T3 (es) Derivados de bisulfuro de indano-2-mercaptoacetilamida utiles como inhibidores de la encefalinasa.
DE69527854D1 (de) Derivate substituierter amidinonaphthylester
FI960588A (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
NO950212L (no) Indolinyl-N-hydroksyurinstoff- og -N-hydroksamsyrederivater som lipoksygenase-inhibitorer
GT199400074A (es) Pirroles substituidos
AR005835A1 (es) Derivados aromaticos sustituidos del acido fosfonico.
NO20012328L (no) Fluorerte 3,4-dihydrokinolinderivater anvendt som NOS- inhibitorer